Two Sigma Advisers’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.81M | Sell |
283,700
-129,000
| -31% | -$823K | ﹤0.01% | 1175 |
|
|
2025
Q1 | $2.01M | Sell |
412,700
-243,800
| -37% | -$1.18M | ﹤0.01% | 1157 |
|
|
2024
Q4 | $6.28M | Buy |
656,500
+81,000
| +14% | +$774K | 0.01% | 632 |
|
|
2024
Q3 | $4.81M | Buy |
575,500
+100
| +0% | +$835 | 0.01% | 713 |
|
|
2024
Q2 | $3.92M | Sell |
575,400
-498,400
| -46% | -$3.4M | 0.01% | 873 |
|
|
2024
Q1 | $2.72M | Sell |
1,073,800
-13,900
| -1% | -$35.2K | 0.01% | 1060 |
|
|
2023
Q4 | $2.61M | Buy |
1,087,700
+20,400
| +2% | +$49K | 0.01% | 1131 |
|
|
2023
Q3 | $3.63M | Buy |
1,067,300
+350,400
| +49% | +$1.19M | 0.01% | 895 |
|
|
2023
Q2 | $5.27M | Buy |
716,900
+227,800
| +47% | +$1.67M | 0.01% | 753 |
|
|
2023
Q1 | $5.07M | Buy |
489,100
+256,200
| +110% | +$2.65M | 0.01% | 803 |
|
|
2022
Q4 | $2.75M | Sell |
232,900
-3,700
| -2% | -$43.7K | 0.01% | 1064 |
|
|
2022
Q3 | $4.97M | Sell |
236,600
-6,300
| -3% | -$132K | 0.01% | 737 |
|
|
2022
Q2 | $7.54M | Sell |
242,900
-24,100
| -9% | -$748K | 0.02% | 602 |
|
|
2022
Q1 | $11M | Buy |
267,000
+123,200
| +86% | +$5.06M | 0.03% | 483 |
|
|
2021
Q4 | $6.25M | Buy |
143,800
+138,400
| +2,563% | +$6.02M | 0.02% | 677 |
|
|
2021
Q3 | $270K | Sell |
5,400
-248,600
| -98% | -$12.4M | ﹤0.01% | 2155 |
|
|
2021
Q2 | $16M | Buy |
+254,000
| New | +$16M | 0.04% | 389 |
|
|
2020
Q4 | – | Sell |
-153,700
| Closed | -$15.9M | – | 2440 |
|
|
2020
Q3 | $15.9M | Buy |
+153,700
| New | +$15.9M | 0.05% | 380 |
|
|
2019
Q3 | – | Sell |
-6,500
| Closed | -$314K | – | 2263 |
|
|
2019
Q2 | $314K | Buy |
+6,500
| New | +$314K | ﹤0.01% | 1998 |
|
|
2019
Q1 | – | Sell |
-6,300
| Closed | -$373K | – | 2334 |
|
|
2018
Q4 | $373K | Sell |
6,300
-10,300
| -62% | -$610K | ﹤0.01% | 1885 |
|
|
2018
Q3 | $1.09M | Sell |
16,600
-26,590
| -62% | -$1.75M | ﹤0.01% | 1475 |
|
|
2018
Q2 | $2.18M | Sell |
43,190
-11,300
| -21% | -$571K | 0.01% | 1257 |
|
|
2018
Q1 | $2.87M | Sell |
54,490
-10,000
| -16% | -$527K | 0.01% | 1074 |
|
|
2017
Q4 | $3M | Buy |
64,490
+9,300
| +17% | +$432K | 0.01% | 1058 |
|
|
2017
Q3 | $2.23M | Sell |
55,190
-19,600
| -26% | -$793K | 0.01% | 1143 |
|
|
2017
Q2 | $2.54M | Sell |
74,790
-21,200
| -22% | -$719K | 0.01% | 1087 |
|
|
2017
Q1 | $2.79M | Sell |
95,990
-38,900
| -29% | -$1.13M | 0.01% | 1095 |
|
|
2016
Q4 | $4.43M | Sell |
134,890
-25,200
| -16% | -$828K | 0.02% | 789 |
|
|
2016
Q3 | $5.05M | Buy |
160,090
+15,700
| +11% | +$495K | 0.02% | 643 |
|
|
2016
Q2 | $4.06M | Buy |
144,390
+19,000
| +15% | +$534K | 0.02% | 616 |
|
|
2016
Q1 | $4.56M | Sell |
125,390
-12,700
| -9% | -$462K | 0.03% | 529 |
|
|
2015
Q4 | $5.53M | Buy |
138,090
+9,600
| +7% | +$384K | 0.03% | 420 |
|
|
2015
Q3 | $3.69M | Sell |
128,490
-9,900
| -7% | -$285K | 0.02% | 553 |
|
|
2015
Q2 | $4.56M | Sell |
138,390
-3,100
| -2% | -$102K | 0.03% | 511 |
|
|
2015
Q1 | $4.07M | Buy |
141,490
+37,200
| +36% | +$1.07M | 0.03% | 544 |
|
|
2014
Q4 | $2.84M | Buy |
104,290
+3,900
| +4% | +$106K | 0.02% | 644 |
|
|
2014
Q3 | $2.14M | Sell |
100,390
-8,500
| -8% | -$181K | 0.02% | 682 |
|
|
2014
Q2 | $2.45M | Sell |
108,890
-89,600
| -45% | -$2.01M | 0.02% | 645 |
|
|
2014
Q1 | $5.02M | Buy |
198,490
+124,600
| +169% | +$3.15M | 0.05% | 369 |
|
|
2013
Q4 | $1.7M | Buy |
73,890
+11,400
| +18% | +$262K | 0.02% | 667 |
|
|
2013
Q3 | $1.19M | Buy |
62,490
+9,150
| +17% | +$174K | 0.01% | 670 |
|
|
2013
Q2 | $769K | Buy |
+53,340
| New | +$769K | 0.01% | 778 |
|